Investing In ATAI Life Sciences N.V. (NASDAQ: ATAI): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of ATAI Life Sciences N.V. is $325.38M. A total of 1.46 million shares were traded on the day, compared to an average of 1.37M shares.

In the most recent transaction, Brand Florian bought 20,000 shares of ATAI for 1.16 per share on Nov 16. After the transaction, the insider now owns 130,000 company shares. In a previous transaction on Sep 13, Brand Florian bought 40,000 shares at 1.45 per share. ATAI shares that the insider owns now total 110,000.

Among the insiders who bought shares, Apeiron Investment Group Ltd. acquired of 1,214,297 shares on Mar 29 at a per-share price of $1.32. This resulted in the 10% Owner holding 32,086,697 shares of ATAI after the transaction. In another insider transaction, Brand Florian bought 70,000 shares at $1.48 per share on Mar 29. Company shares held by the insider now total 70,000.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ATAI in the last 3 months, the mean price target is $14.50 with high estimates of $21.00 and low estimates of $6.00. In terms of 52-week highs and lows, ATAI has a high of $2.39 and a low of $1.02.

As of this writing, ATAI has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.19.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ATAI’s latest balance sheet shows that the firm has $362.27M in Cash & Short Term Investments as of fiscal 2021. There were $743.00k in debt and $20.93M in liabilities at the time. Its Book Value Per Share was $1.60, while its Total Shareholder’s Equity was $385.96M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATAI is Buy with a score of 4.60.

Most Popular

Related Posts